Company Gelesis Holdings, Inc.

Equities

GLSH.Q

US36850R2040

Pharmaceuticals

End-of-day quote OTC Markets 07:00:00 2024-03-19 pm EDT 5-day change 1st Jan Change
0.0198 USD +1,979,900.00% Intraday chart for Gelesis Holdings, Inc. 0.00% +1,220.00%

Business Summary

Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).

Number of employees: 93

Sales per Business

USD in Million2021Weight2022Weight Delta
Plenity
99.2 %
- - 26 99.2 % -
Licensing
0.8 %
- - 0 0.8 % -

Sales per region

USD in Million2021Weight2022Weight Delta
United States and Italy
100.0 %
-- 26 100.0 % -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 73,335,110 34,687,393 ( 47.30 %) 0 47.30 %

Shareholders

NameEquities%Valuation
Puretech Health LLC
22.81 %
16,727,582 22.81 % 33 455 $
HPSO SPV Ltd.
16.61 %
12,181,993 16.61 % 24 364 $
KLP Enterprises LLC
16.44 %
12,056,626 16.44 % 24 113 $
4,501,770 6.139 % 9 004 $
1,224,391 1.670 % 2 449 $
1,204,879 1.643 % 2 410 $
1,110,668 1.515 % 2 221 $
510,768 0.6965 % 1 022 $
190,264 0.2594 % 381 $
David Pass
0.2177 %
159,627 0.2177 % 319 $
NameEquities%Valuation
JPMorgan Alternative Asset Management, Inc.
-
100,010 - 100 $
NameEquities%Valuation
Capstar Sponsor Group LLC
100.00 %
6,837,000 100.00 % 13 674 $

Company contact information

Gelesis Holdings, Inc.

501 Boylston Street Suite 6102

02116, Boston

+

http://www.gelesis.com
address Gelesis Holdings, Inc.(GLSH.Q)